“gene-therapy” Archives

in
Entry Author Date Location
NeuroVia Raises $14M to Test Drug for Rare, Fatal Metabolic Disease 07/20/17 Boston
Bio Roundup: PDUFA Progress, BCRA Redux, CAR-T Thumbs Up, & More 07/14/17 National
Bio Roundup: Senate Drama, A.I. Stories, Data Dives, Shkreli & More 06/30/17 National
LogicBio Lands $45M for Gene Therapies in Rare Pediatric Diseases 06/28/17 Boston
Boston Is Arguably the Heart of Biotech. But Who Makes It So? Have Your Say. 06/26/17 Boston
Bio Roundup: Senate Trumpcare, FDA On Cancer, Alzheimer Review & More 06/23/17 National
Bluebird Reports Early Results From Upgraded Gene Therapy 06/23/17 Boston
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
With Gene Therapy for Diabetes, San Antonio Researcher Eyes Funding 05/31/17 Texas
Bio Roundup: Spinraza Woes, Science March, Baseline Launch & More 04/21/17 National
UniQure to Yank Pioneering Gene Therapy From Market in Europe 04/20/17 Boston
Frequency Nabs $32M, Will Push Hearing-Loss Drugs To Human Studies 04/11/17 Boston
Angionetics Nears Key Gene Therapy Trial for Coronary Heart Disease 04/04/17 San Diego
Next Stop on Father’s Duchenne Quest: Wall Street? Solid Raises $50M 03/30/17 Boston
Tocagen Plans IPO to Finance Trials of Gene Therapy in Brain Cancer 03/10/17 San Diego
Nonprofit Seeds Exonics to Fund Push For CRISPR Duchenne Treatment 02/27/17 Boston
His Gene Therapy Near Approval, Spark CEO Wonders: What Price Vision? 02/16/17 New York
Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins 02/03/17 National
Investors Sour on Data Debut For Dimension’s Hemophilia Gene Therapy 01/31/17 Boston
Notes From The JPM ’17 Vortex: Trump, Rainstorms & The Price You Pay 01/13/17 National
14 For ’17: Key Clinical Data to Watch For Next Year (Part 1) 12/21/16 National
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More 12/09/16 National
Voyager’s Gene Therapy for Parkinson’s Shows Promise in Small Study 12/07/16 Boston
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
Fresh Off ASH Data, Spark Teams With Selecta to Boost Gene Therapies 12/05/16 Boston
Struggling UniQure Cuts Gene Therapies, Jobs, in Big Restructuring 11/15/16 Boston
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
New Data Show Power, Limits of Bluebird’s Gene Therapy For Blood Diseases 11/03/16 Boston
Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More 10/14/16 National
With Upgraded Tech, Bluebird Updates Regulatory Path For Gene Therapy 10/13/16 Boston
Page 1 of 8 next page »